Huadong Medicine Co., Ltd (SHE:000963)
36.90
-0.23 (-0.62%)
Mar 28, 2025, 3:04 PM CST
Huadong Medicine Revenue
Huadong Medicine had revenue of 10.51B CNY in the quarter ending September 30, 2024, with 5.03% growth. This brings the company's revenue in the last twelve months to 41.71B, up 3.62% year-over-year. In the year 2023, Huadong Medicine had annual revenue of 40.62B with 7.71% growth.
Revenue (ttm)
41.71B
Revenue Growth
+3.62%
P/S Ratio
1.55
Revenue / Employee
2.46M
Employees
16,969
Market Cap
64.58B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 40.62B | 2.91B | 7.71% |
Jan 1, 2023 | 37.71B | 3.15B | 9.12% |
Jan 1, 2022 | 34.56B | 880.24M | 2.61% |
Dec 31, 2020 | 33.68B | -1.76B | -4.97% |
Dec 31, 2019 | 35.45B | 4.78B | 15.60% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 26.00B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |